Abstract:【Abstract】 Objective To measure the roles of fibroblast growth factor 21 (FGF21) on hypoxia/reoxygenation (H/R)treated cardiomyocytes and the potential mechanisms. Methods Adenoviral vector encoding FGF21 (AdFGF21) was used to elevate FGF21 in cultured neonatal rat cardiomyocytes. The experiments were assigned into four groups: control group, H/R group, H/R+AdGFP group and H/R+ AdFGF21 group. Three hours of hypoxia and 3h of reoxygenation were performed to cause H/R injury followed after viral transfection. Cell viability was detected by CCK8 assay. The apoptosis, ROS and molecular alternations were systematically estimated. Moreover, the specific PI3K/AKT inhibitor (LY294002) was added in mechanistic detections. Results In comparison with the control group, H/R resulted in the downregulation of FGF21 followed by the worsened cardiomyocytes damage, as exhibited by the decrease of viability and the promotion of ROS and apoptosis. However, above parameters induced by H/R were attenuated by FGF21 overexpression. Mechanistic experiments showed that FGF21 elevation enhanced the levels of pPI3K/AKT, and blocking PI3K/AKT with its specific inhibitor LY294002 dampened the H/Rlimited effects of FGF21. Conclusion FGF21 ameliorates myocardial H/R injury in part via a PI3K/AKTdependent way.